![Ajan Reginald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ajan Reginald
Gründer bei
Cell Therapy Ltd.
Vermögen: 2 Mio $ am 31.12.2025
Profil
Ajan Trevor Reginald is the founder of Cell Therapy Ltd., established in 2009, serving as Chief Executive Officer & Executive Director.
Current jobs include Chairman at Oncogeni Ltd., Director at Desktop Genetics Ltd., and Managing Director, Secretary & Executive Director at Cardiogeni Plc since 2019.
Former jobs include Director-Business Development at Roche Pharmaceuticals, Inc., Chief Executive Director & Executive Director at Coiled Therapeutics Plc from 2022 to 2025, Global Head-Emerging Technologies at Roche Group, and Chief Operating & Technology Officer at Novacyt SAS. Education history includes graduate studies at the University of Oxford, undergraduate studies at the University of London, and an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases 24,94 % | 21.04.2026 | 22.223.711 ( 24,94 % ) | 2 Mio $ | 31.12.2025 |
COILED THERAPEUTICS PLC 0,09 % | 24.11.2025 | 380.508 ( 0,09 % ) | 47 978 $ | 30.06.2026 |
Aktive Positionen von Ajan Reginald
| Unternehmen | Position | Beginn |
|---|---|---|
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Gründer | 01.01.2009 |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Vorstandsvorsitzender | 28.12.2016 |
Desktop Genetics Ltd.
 Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Direktor/Vorstandsmitglied | - |
Oncogeni Ltd.
 Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Vorsitzender | - |
Ehemalige bekannte Positionen von Ajan Reginald
| Unternehmen | Position | Ende |
|---|---|---|
| ROQT THER | Vorstandsvorsitzender | 17.03.2025 |
| NOVACYT | Geschäftsführer | - |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | - |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | - |
Ausbildung von Ajan Reginald
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacyt SAS
 Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases | Health Technology |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology firm | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Desktop Genetics Ltd.
Desktop Genetics Ltd. Packaged SoftwareTechnology Services Develops software tools to enable literal desktop genetics | Technology Services |
Celixir Plc
Celixir Plc Pharmaceuticals: MajorHealth Technology Discovers and develops regenerative medicines to treat life threatening and life altering diseases | Health Technology |
Roquefort Therapeutics Plc
 Roquefort Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops pre-clinical next generation medicines for cancer treatment | Health Technology |
Oncogeni Ltd.
Oncogeni Ltd. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Wählen Sie MarketScreener 
